Biodesix, Inc. Common Stock (BDSX) is a publicly traded Healthcare sector company. As of July 22, 2026, BDSX trades at $21.97 with a market cap of $205.15M and a P/E ratio of -7.86. BDSX moved +3.55% today. Year to date, BDSX is +210.88%; over the trailing twelve months it is +202.00%. Its 52-week range spans $3.44 to $32.20. Analyst consensus is strong buy with an average price target of $31.00. Rallies surfaces BDSX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest BDSX news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $21.97 |
| Market Cap | $205.15M |
| P/E Ratio | -7.86 |
| EPS | $-2.48 |
| Dividend Yield | 0.00% |
| 52-Week High | $32.20 |
| 52-Week Low | $3.44 |
| Volume | 13.87K |
| Avg Volume | 0 |
| Revenue (TTM) | $96.10M |
| Net Income | $-31.96M |
| Gross Margin | 0.00% |
7 analysts cover BDSX: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $31.00.